Literature DB >> 16271645

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Salim Yusuf1, Steven Hawken, Stephanie Ounpuu, Leonelo Bautista, Maria Grazia Franzosi, Patrick Commerford, Chim C Lang, Zvonko Rumboldt, Churchill L Onen, Liu Lisheng, Supachai Tanomsup, Paul Wangai, Fahad Razak, Arya M Sharma, Sonia S Anand.   

Abstract

BACKGROUND: Obesity is a major risk factor for cardiovascular disease, but the most predictive measure for different ethnic populations is not clear. We aimed to assess whether markers of obesity, especially waist-to-hip ratio, would be stronger indicators of myocardial infarction than body-mass index (BMI), the conventional measure.
METHODS: We did a standardised case-control study of acute myocardial infarction with 27 098 participants in 52 countries (12,461 cases and 14,637 controls) representing several major ethnic groups. We assessed the relation between BMI, waist and hip circumferences, and waist-to-hip ratio to myocardial infarction overall and for each group.
FINDINGS: BMI showed a modest and graded association with myocardial infarction (OR 1.44, 95% CI 1.32-1.57 top quintile vs bottom quintile before adjustment), which was substantially reduced after adjustment for waist-to-hip ratio (1.12, 1.03-1.22), and non-significant after adjustment for other risk factors (0.98, 0.88-1.09). For waist-to-hip ratio, the odds ratios for every successive quintile were significantly greater than that of the previous one (2nd quintile: 1.15, 1.05-1.26; 3rd quintile: 1.39; 1.28-1.52; 4th quintile: 1.90, 1.74-2.07; and 5th quintiles: 2.52, 2.31-2.74 [adjusted for age, sex, region, and smoking]). Waist (adjusted OR 1.77; 1.59-1.97) and hip (0.73; 0.66-0.80) circumferences were both highly significant after adjustment for BMI (p<0.0001 top vs bottom quintiles). Waist-to-hip ratio and waist and hip circumferences were closely (p<0.0001) associated with risk of myocardial infarction even after adjustment for other risk factors (ORs for top quintile vs lowest quintiles were 1.75, 1.33, and 0.76, respectively). The population-attributable risks of myocardial infarction for increased waist-to-hip ratio in the top two quintiles was 24.3% (95% CI 22.5-26.2) compared with only 7.7% (6.0-10.0) for the top two quintiles of BMI.
INTERPRETATION: Waist-to-hip ratio shows a graded and highly significant association with myocardial infarction risk worldwide. Redefinition of obesity based on waist-to-hip ratio instead of BMI increases the estimate of myocardial infarction attributable to obesity in most ethnic groups.

Entities:  

Mesh:

Year:  2005        PMID: 16271645     DOI: 10.1016/S0140-6736(05)67663-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  720 in total

1.  Visceral adiposity in young patients with coronary artery disease-a case control study.

Authors:  Blessan Varghese; Smrita Swamy; M A Srilakshmi; M J Santhosh; Gurappa G Shetty; Kiron Varghese; Chandrakant B Patil; Shamanna S Iyengar
Journal:  Indian Heart J       Date:  2012 May-Jun

2.  Changes in body mass index, waist and hip circumferences, waist to hip ratio and risk of all-cause mortality in men.

Authors:  S V Mousavi; R Mohebi; A Mozaffary; F Sheikholeslami; F Azizi; F Hadaegh
Journal:  Eur J Clin Nutr       Date:  2014-11-05       Impact factor: 4.016

Review 3.  The efficacy of long-term conjugated linoleic acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Igho J Onakpoya; Paul P Posadzki; Leala K Watson; Lucy A Davies; Edzard Ernst
Journal:  Eur J Nutr       Date:  2011-10-12       Impact factor: 5.614

4.  CrossTalk proposal: Most of the cardiovascular consequences of OSA are due to increased sympathetic activity.

Authors:  Malcolm Kohler; John R Stradling
Journal:  J Physiol       Date:  2012-06-15       Impact factor: 5.182

5.  Correlations of neck circumference with body composition and cardiometabolic risk factors in Arab women.

Authors:  Reem S Albassam; Kai Y Lei; Abdullah M Alnaami; Nasser M Al-Daghri
Journal:  Eat Weight Disord       Date:  2019-01-02       Impact factor: 4.652

6.  Prognostic impact of comorbidity in patients with bladder cancer.

Authors:  Ifeanyichukwu I Megwalu; Anna Vlahiotis; Mohamed Radwan; Jay F Piccirillo; Adam S Kibel
Journal:  Eur Urol       Date:  2007-11-05       Impact factor: 20.096

7.  Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease.

Authors:  V M Herrera; J P Casas; J J Miranda; P Perel; R Pichardo; A González; J R Sanchez; C Ferreccio; X Aguilera; E Silva; M Oróstegui; L F Gómez; J A Chirinos; J Medina-Lezama; C M Pérez; E Suárez; A P Ortiz; L Rosero; N Schapochnik; Z Ortiz; D Ferrante; M Diaz; L E Bautista
Journal:  Int J Obes (Lond)       Date:  2009-02-24       Impact factor: 5.095

8.  Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  F Higashikawa; M Noda; T Awaya; N Danshiitsoodol; Y Matoba; T Kumagai; M Sugiyama
Journal:  Eur J Clin Nutr       Date:  2016-03-09       Impact factor: 4.016

9.  The relationship of violence and traumatic stress to changes in weight and waist circumference: longitudinal analyses from the study of women's health across the nation.

Authors:  Lorena Garcia; Lihong Qi; Marianne Rasor; Cari Jo Clark; Joyce Bromberger; Ellen B Gold
Journal:  J Interpers Violence       Date:  2013-11-07

10.  Ambulatory blood pressure monitoring for risk stratification in obese and non-obese subjects from 10 populations.

Authors:  T W Hansen; L Thijs; Y Li; J Boggia; Y Liu; K Asayama; M Kikuya; K Björklund-Bodegård; T Ohkubo; J Jeppesen; C Torp-Pedersen; E Dolan; T Kuznetsova; K Stolarz-Skrzypek; V Tikhonoff; S Malyutina; E Casiglia; Y Nikitin; L Lind; E Sandoya; K Kawecka-Jaszcz; J Filipovský; Y Imai; J Wang; E O'Brien; J A Staessen
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.